Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceImmunity

Echinacea

The most-studied cold remedy in the supplement aisle, and still an unresolved one: the Cochrane review of 24 trials found no reliable treatment effect and only a small, statistically fragile prevention signal. Product-to-product variability in species and plant part makes the literature nearly impossible to pool.

What the science says

  • Treating an established cold Limited evidence

    The 2014 Cochrane review (24 trials, ~4,600 participants) concluded that Echinacea products do not reliably shorten or lessen a cold once symptoms have started; individual positive trials exist but are outweighed by null results and heterogeneity. Where an effect was seen, it amounted to roughly half a day to a day and a half of illness — within the noise of unblinded symptom diaries.

  • Preventing colds and respiratory infections Limited evidence

    Cochrane found a weak prevention trend (relative risk ~0.83-0.90) that lost significance in most sensitivity analyses. An industry-linked meta-analysis of 6 trials (Schapowal 2015) reported a 35% reduction in recurrent infections and fewer complications, but it pooled a narrow set of trials on one alcoholic E. purpurea extract and is not independent confirmation.

  • Preparations are not interchangeable Limited evidence

    Trials have used E. purpurea, E. angustifolia and E. pallida, and root versus aerial parts, in pressed juice, alcoholic tincture and dried powder. Marker compounds (alkylamides, cichoric acid) vary several-fold between commercial products, so a positive trial on one extract says little about the bottle on the shelf.

Dosage & safety

Studied doseTrial doses vary by preparation. Pressed juice of E. purpurea aerial parts: 6-9 mL/day. Standardized alcoholic extract (e.g. 2,400 mg/day of a 1:11 tincture) during the cold season, raised to 4,000 mg/day at symptom onset. Dried root: 900-1,500 mg/day in divided doses. Typical courses run 7-10 days for treatment and up to 4 months for prevention.
SafetyGenerally well tolerated; the commonest complaints are rash, GI upset and unpleasant taste. Echinacea is in the Asteraceae family, so people allergic to ragweed, chrysanthemums, marigolds or daisies can react, and anaphylaxis has been reported (Australia's TGA issued a warning after ~50 hypersensitivity reports). Rare hepatitis and autoimmune-flare case reports exist. Avoid in progressive systemic disease (tuberculosis, HIV, multiple sclerosis) and with immunosuppressants such as tacrolimus or ciclosporin, since immune-modulating effects are theoretically opposed. It weakly inhibits CYP1A2 and may affect caffeine clearance. Data in pregnancy are limited but not alarming.

Scientific references

Where to buy

Nature's Way, Echinacea Purpurea Herb, 180 Vegan Capsules (400 mg per Capsule)

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Immunity